Scientific Publications
Biologic therapies in the treatment of psoriasis: a comprehensive evidence-based basic science and clinical review and a practical guide to tuberculosis monitoring.
Sivamani RK, Goodarzi H, Garcia MS, Raychaudhuri SP, Wehrli LN, Ono Y, Maverakis E. 2013 Apr;44(2):121-40
Management of recalcitrant hidradenitissuppurativa with ustekinumab.
Sharon VR, Garcia MS, Bagheri S, Goodarzi H, Yang C, Ono Y, Maverakis E. 2012 May;92(3):320-1..
The Etiology of Paraneoplastic Autoimmunity.
Maverakis E, Goodarzi H, Wehrli LN, Ono Y, Garcia MS. 2012 Apr;42(2):135-44.
IgE, Mast Cells, and Eosinophils in Atopic Dermatitis.
Liu FT, Goodarzi H, Chen HY. 2011 Dec;41(3):298-310.
Part I: Program Spotlight - The UC Davis Department of Dermatology Residency Training Program.
Tuerk M, Goodarzi H, Youker S. 2011 Mar 1;10(3):253-4.
Complete Regression of Subcutaneous and Cutaneous Metastatic Melanoma with High-Dose Intralesional Interleukin-2 in Combination with Topical Imiquimod and Retinoid Cream.
Garcia MS, Ono Y, Martinez SR, Chen SL, Goodarzi H, Phan T, Wehrli LN, Miyamura Y, Fung MA and Maverakis E. 2011 Jun;21(3):235-43.
Light, including ultraviolet.
Maverakis E, Miyamura Y, Bowen MP, Correa G, Ono Y, Goodarzi H. 2010 May;34(3):J247-57. Epub 2009 Dec 16. Review.
Erythema induratum of Bazin.
Sharon V, Goodarzi H, Chambers CJ, Fung MA, Armstrong AW. 2010 Apr 15;16(4):1..
Innate immunity: a cutaneous perspective.
Goodarzi H, Trowbridge J, Gallo RL. 2007 Oct; 33(1-2):15-26.
Elimination of maternally transmitted autoantibodies prevents diabetes in nonobese diabetic mice.
Greeley SA, Katsumata M, Yu L, Eisenbarth GS, Moore DJ, Goodarzi H, Barker CF, Naji A, Noorchashm H. 2002 Apr; 8(4):399-402.
Recognition of hyaluronan released in sterile injury involves a unique receptor complex dependent on Toll-like receptor 4, CD44, and MD-2.
Taylor KR, Yamasaki K, Radek KA, Di Nardo A, Goodarzi H, Golenbock D, Beutler B, Gallo RL. 2007 Jun 22; 282(25):18265-75.